<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34769048</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>21</Issue><PubDate><Year>2021</Year><Month>Oct</Month><Day>27</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Swim Training Ameliorates Hyperlocomotion of ALS Mice and Increases Glutathione Peroxidase Activity in the Spinal Cord.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">11614</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms222111614</ELocationID><Abstract><AbstractText>(1) Background: Amyotrophic lateral sclerosis (ALS) is an incurable, neurodegenerative disease. In some cases, ALS causes behavioral disturbances and cognitive dysfunction. Swimming has revealed a neuroprotective influence on the motor neurons in ALS. (2) Methods: In the present study, a SOD1-G93A mice model of ALS were used, with wild-type B6SJL mice as controls. ALS mice were analyzed before ALS onset (10th week of life), at ALS 1 onset (first symptoms of the disease, ALS 1 onset, and ALS 1 onset SWIM), and at terminal ALS (last stage of the disease, ALS TER, and ALS TER SWIM), and compared with wild-type mice. Swim training was applied 5 times per week for 30 min. All mice underwent behavioral tests. The spinal cord was analyzed for the enzyme activities and oxidative stress markers. (3) Results: Pre-symptomatic ALS mice showed increased locomotor activity versus control mice; the swim training reduced these symptoms. The metabolic changes in the spinal cord were present at the pre-symptomatic stage of the disease with a shift towards glycolytic processes at the terminal stage of ALS. Swim training caused an adaptation, resulting in higher glutathione peroxidase (GPx) and protection against oxidative stress. (4) Conclusion: Therapeutic aquatic activity might slow down the progression of ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dzik</LastName><ForeName>Katarzyna Patrycja</ForeName><Initials>KP</Initials><Identifier Source="ORCID">0000-0001-5414-7479</Identifier><AffiliationInfo><Affiliation>Department of Animal and Human Physiology, Faculty of Biology, University of Gdansk, 80-309 Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flis</LastName><ForeName>Damian J&#xf3;zef</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0002-6176-4536</Identifier><AffiliationInfo><Affiliation>Department of Pharmaceutical Pathophysiology, Faculty of Pharmacy, Medical University of Gdansk, 80-211 Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bytowska</LastName><ForeName>Zofia Kinga</ForeName><Initials>ZK</Initials><Identifier Source="ORCID">0000-0003-4796-378X</Identifier><AffiliationInfo><Affiliation>Division of Bioenergetics and Physiology of Exercise, Faculty of Health Sciences with Institute of Maritime and Tropical Medicine, Medical University of Gdansk, 80-211 Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karnia</LastName><ForeName>Mateusz Jakub</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-3301-0446</Identifier><AffiliationInfo><Affiliation>Department of Animal and Human Physiology, Faculty of Biology, University of Gdansk, 80-309 Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziolkowski</LastName><ForeName>Wieslaw</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0001-8371-4153</Identifier><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Faculty of Health Sciences with Institute of Maritime and Tropical Medicine, Medical University of Gdansk, 80-219 Gdansk, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaczor</LastName><ForeName>Jan Jacek</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Animal and Human Physiology, Faculty of Biology, University of Gdansk, 80-309 Gdansk, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2018/29/N/NZ7/01627</GrantID><Agency>National Science Center</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.11.1.9</RegistryNumber><NameOfSubstance UI="D005979">Glutathione Peroxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005979" MajorTopicYN="N">Glutathione Peroxidase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008124" MajorTopicYN="N">Locomotion</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013550" MajorTopicYN="N">Swimming</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">hyperlocomotion</Keyword><Keyword MajorTopicYN="N">metabolism</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">spinal cord</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>13</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34769048</ArticleId><ArticleId IdType="pmc">PMC8583724</ArticleId><ArticleId IdType="doi">10.3390/ijms222111614</ArticleId><ArticleId IdType="pii">ijms222111614</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Martin L.J. Biology of mitochondria in neurodegenerative diseases. Prog. Mol. Biol. Transl. Sci. 2012;107:355&#x2013;415. doi: 10.1016/B978-0-12-385883-2.00005-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-385883-2.00005-9</ArticleId><ArticleId IdType="pmc">PMC3530202</ArticleId><ArticleId IdType="pubmed">22482456</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;364:362. doi: 10.1038/364362c0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/364362c0</ArticleId><ArticleId IdType="pubmed">8332197</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddi A.R., Culotta V.C. SOD1 integrates signals from oxygen and glucose to repress respiration. Cell. 2013;152:224&#x2013;235. doi: 10.1016/j.cell.2012.11.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.11.046</ArticleId><ArticleId IdType="pmc">PMC3552299</ArticleId><ArticleId IdType="pubmed">23332757</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber S.C., Shaw P.J. Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target. Free Radic. Biol. Med. 2010;48:629&#x2013;641. doi: 10.1016/j.freeradbiomed.2009.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.11.018</ArticleId><ArticleId IdType="pubmed">19969067</ArticleId></ArticleIdList></Reference><Reference><Citation>Hor J.H., Santosa M.M., Lim V.J.W., Ho B.X., Taylor A., Khong Z.J., Ravits J., Fan Y., Liou Y.C., Soh B.S., et al. ALS motor neurons exhibit hallmark metabolic defects that are rescued by SIRT3 activation. Cell Death Differ. 2021;28:1379&#x2013;1397. doi: 10.1038/s41418-020-00664-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-00664-0</ArticleId><ArticleId IdType="pmc">PMC8027637</ArticleId><ArticleId IdType="pubmed">33184465</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi S., Abramov A.Y. Mechanism of oxidative stress in neurodegeneration. Oxid. Med. Cell. Longev. 2012;2012:428010. doi: 10.1155/2012/428010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/428010</ArticleId><ArticleId IdType="pmc">PMC3362933</ArticleId><ArticleId IdType="pubmed">22685618</ArticleId></ArticleIdList></Reference><Reference><Citation>Flis D.J., Dzik K., Kaczor J.J., Halon-Golabek M., Antosiewicz J., Wieckowski M.R., Ziolkowski W. Swim Training Modulates Skeletal Muscle Energy Metabolism, Oxidative Stress, and Mitochondrial Cholesterol Content in Amyotrophic Lateral Sclerosis Mice. Oxid. Med. Cell. Longev. 2018;2018:5940748. doi: 10.1155/2018/5940748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/5940748</ArticleId><ArticleId IdType="pmc">PMC5924974</ArticleId><ArticleId IdType="pubmed">29849903</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L., Li X., Li C., Tsang R.C.C., Chen Y., Ge Y., Gao Q. Effects of Exercise in Patients With Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. Am. J. Phys. Med. Rehabil. 2020;99:801&#x2013;810. doi: 10.1097/PHM.0000000000001419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001419</ArticleId><ArticleId IdType="pubmed">32452880</ArticleId></ArticleIdList></Reference><Reference><Citation>Deforges S., Branchu J., Biondi O., Grondard C., Pariset C., Lecolle S., Lopes P., Vidal P.P., Chanoine C., Charbonnier F. Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. J. Physiol. 2009;587:3561&#x2013;3572. doi: 10.1113/jphysiol.2009.169748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2009.169748</ArticleId><ArticleId IdType="pmc">PMC2742281</ArticleId><ArticleId IdType="pubmed">19491245</ArticleId></ArticleIdList></Reference><Reference><Citation>Just-Borras L., Hurtado E., Cilleros-Mane V., Biondi O., Charbonnier F., Tomas M., Garcia N., Tomas J., Lanuza M.A. Running and swimming prevent the deregulation of the BDNF/TrkB neurotrophic signalling at the neuromuscular junction in mice with amyotrophic lateral sclerosis. Cell. Mol. Life Sci. CMLS. 2020;77:3027&#x2013;3040. doi: 10.1007/s00018-019-03337-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03337-5</ArticleId><ArticleId IdType="pubmed">31646358</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilak M., Wu L., Wang Q., Haughey N., Conant K., St Hillaire C., Andreasson K. PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis. Ann. Neurol. 2004;56:240&#x2013;248. doi: 10.1002/ana.20179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20179</ArticleId><ArticleId IdType="pubmed">15293276</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerber Y.N., Sabourin J.C., Hugnot J.P., Perrin F.E. Unlike physical exercise, modified environment increases the lifespan of SOD1G93A mice however both conditions induce cellular changes. PLoS ONE. 2012;7:e45503. doi: 10.1371/journal.pone.0045503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0045503</ArticleId><ArticleId IdType="pmc">PMC3447796</ArticleId><ArticleId IdType="pubmed">23029057</ArticleId></ArticleIdList></Reference><Reference><Citation>Viggiano D. The hyperactive syndrome: Metanalysis of genetic alterations, pharmacological treatments and brain lesions which increase locomotor activity. Behav. Brain Res. 2008;194:1&#x2013;14. doi: 10.1016/j.bbr.2008.06.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2008.06.033</ArticleId><ArticleId IdType="pubmed">18656502</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteloup C., Desport J.C., Clavelou P., Guy N., Derumeaux-Burel H., Ferrier A., Couratier P. Hypermetabolism in ALS patients: An early and persistent phenomenon. J. Neurol. 2009;256:1236&#x2013;1242. doi: 10.1007/s00415-009-5100-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5100-z</ArticleId><ArticleId IdType="pubmed">19306035</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport J.C., Preux P.M., Magy L., Boirie Y., Vallat J.M., Beaufrere B., Couratier P. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am. J. Clin. Nutr. 2001;74:328&#x2013;334. doi: 10.1093/ajcn/74.3.328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/74.3.328</ArticleId><ArticleId IdType="pubmed">11522556</ArticleId></ArticleIdList></Reference><Reference><Citation>Funalot B., Desport J.C., Sturtz F., Camu W., Couratier P. High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis. 2009;10:113&#x2013;117. doi: 10.1080/17482960802295192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802295192</ArticleId><ArticleId IdType="pubmed">18792852</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B., Desport J.C., Kajeu P., Jesus P., Nicolaud B., Nicol M., Preux P.M., Couratier P. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J. Neurol. Neurosurg. Psychiatry. 2011;82:628&#x2013;634. doi: 10.1136/jnnp.2010.211474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.211474</ArticleId><ArticleId IdType="pubmed">21097551</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn F.J., Ioannides Z.A., van Eijk R.P.A., Heggie S., Thorpe K.A., Ceslis A., Heshmat S., Henders A.K., Wray N.R., van den Berg L.H., et al. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J. Neurol. Neurosurg. Psychiatry. 2018;89:1016&#x2013;1023. doi: 10.1136/jnnp-2017-317887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317887</ArticleId><ArticleId IdType="pmc">PMC6166607</ArticleId><ArticleId IdType="pubmed">29706605</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaisman N., Lusaus M., Nefussy B., Niv E., Comaneshter D., Hallack R., Drory V.E. Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs? J. Neurol. Sci. 2009;279:26&#x2013;29. doi: 10.1016/j.jns.2008.12.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2008.12.027</ArticleId><ArticleId IdType="pubmed">19185883</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruestle D.A., Cutler R.G., Telljohann R.S., Mattson M.P. Decline in daily running distance presages disease onset in a mouse model of ALS. Neuromol. Med. 2009;11:58&#x2013;62. doi: 10.1007/s12017-009-8064-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12017-009-8064-3</ArticleId><ArticleId IdType="pmc">PMC2706299</ArticleId><ArticleId IdType="pubmed">19418268</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood C.A., Westgate K., Gunstone S., Brage S., Wareham N.J., McDermott C.J., Shaw P.J. Long-term physical activity: An exogenous risk factor for sporadic amyotrophic lateral sclerosis? Amyotroph. Lateral Scler. Front. Degener. 2016;17:377&#x2013;384. doi: 10.3109/21678421.2016.1154575.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1154575</ArticleId><ArticleId IdType="pmc">PMC4950417</ArticleId><ArticleId IdType="pubmed">26998882</ArticleId></ArticleIdList></Reference><Reference><Citation>Flis D.J., Dzik K., Kaczor J.J., Cieminski K., Halon-Golabek M., Antosiewicz J., Wieckowski M.R., Ziolkowski W. Swim Training Modulates Mouse Skeletal Muscle Energy Metabolism and Ameliorates Reduction in Grip Strength in a Mouse Model of Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2019;20:233. doi: 10.3390/ijms20020233.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20020233</ArticleId><ArticleId IdType="pmc">PMC6359093</ArticleId><ArticleId IdType="pubmed">30634386</ArticleId></ArticleIdList></Reference><Reference><Citation>Padilla E., Shumake J., Barrett D.W., Holmes G., Sheridan E.C., Gonzalez-Lima F. Novelty-evoked activity in open field predicts susceptibility to helpless behavior. Physiol. Behav. 2010;101:746&#x2013;754. doi: 10.1016/j.physbeh.2010.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physbeh.2010.08.017</ArticleId><ArticleId IdType="pmc">PMC2975894</ArticleId><ArticleId IdType="pubmed">20804778</ArticleId></ArticleIdList></Reference><Reference><Citation>Linares E., Seixas L.V., dos Prazeres J.N., Ladd F.V., Ladd A.A., Coppi A.A., Augusto O. Tempol moderately extends survival in a hSOD1(G93A) ALS rat model by inhibiting neuronal cell loss, oxidative damage and levels of non-native hSOD1(G93A) forms. PLoS ONE. 2013;8:e55868. doi: 10.1371/journal.pone.0055868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0055868</ArticleId><ArticleId IdType="pmc">PMC3566093</ArticleId><ArticleId IdType="pubmed">23405225</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed R.M., Irish M., Piguet O., Halliday G.M., Ittner L.M., Farooqi S., Hodges J.R., Kiernan M.C. Amyotrophic lateral sclerosis and frontotemporal dementia: Distinct and overlapping changes in eating behaviour and metabolism. Lancet Neurol. 2016;15:332&#x2013;342. doi: 10.1016/S1474-4422(15)00380-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)00380-4</ArticleId><ArticleId IdType="pubmed">26822748</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogden A., Foley G., Henderson R.D., James N., Aoun S.M. Amyotrophic lateral sclerosis: Improving care with a multidisciplinary approach. J. Multidiscip. Healthc. 2017;10:205&#x2013;215. doi: 10.2147/JMDH.S134992.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JMDH.S134992</ArticleId><ArticleId IdType="pmc">PMC5446964</ArticleId><ArticleId IdType="pubmed">28579792</ArticleId></ArticleIdList></Reference><Reference><Citation>Kino Y., Washizu C., Kurosawa M., Yamada M., Miyazaki H., Akagi T., Hashikawa T., Doi H., Takumi T., Hicks G.G., et al. FUS/TLS deficiency causes behavioral and pathological abnormalities distinct from amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2015;3:24. doi: 10.1186/s40478-015-0202-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-015-0202-6</ArticleId><ArticleId IdType="pmc">PMC4408580</ArticleId><ArticleId IdType="pubmed">25907258</ArticleId></ArticleIdList></Reference><Reference><Citation>Grondard C., Biondi O., Pariset C., Lopes P., Deforges S., Lecolle S., Gaspera B.D., Gallien C.L., Chanoine C., Charbonnier F. Exercise-induced modulation of calcineurin activity parallels the time course of myofibre transitions. J. Cell. Physiol. 2008;214:126&#x2013;135. doi: 10.1002/jcp.21168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.21168</ArticleId><ArticleId IdType="pubmed">17559060</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies F.M., Grierson A.J., Cookson M.R., Heath P.R., Tomkins J., Figlewicz D.A., Ince P.G., Shaw P.J. Selective loss of neurofilament expression in Cu/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis. J. Neurochem. 2002;82:1118&#x2013;1128. doi: 10.1046/j.1471-4159.2002.01045.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2002.01045.x</ArticleId><ArticleId IdType="pubmed">12358759</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko I.G., Kim S.E., Kim T.W., Ji E.S., Shin M.S., Kim C.J., Hong M.H., Bahn G.H. Swimming exercise alleviates the symptoms of attention-deficit hyperactivity disorder in spontaneous hypertensive rats. Mol. Med. Rep. 2013;8:393&#x2013;400. doi: 10.3892/mmr.2013.1531.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2013.1531</ArticleId><ArticleId IdType="pubmed">23779147</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva L.A.D., Doyenart R., Henrique Salvan P., Rodrigues W., Felipe Lopes J., Gomes K., Thirupathi A., Pinho R.A., Silveira P.C. Swimming training improves mental health parameters, cognition and motor coordination in children with Attention Deficit Hyperactivity Disorder. Int. J. Environ. Health Res. 2020;30:584&#x2013;592. doi: 10.1080/09603123.2019.1612041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09603123.2019.1612041</ArticleId><ArticleId IdType="pubmed">31081373</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso A.M., Manfredi L.H., Zanini D., Bagatini M.D., Gutierres J.M., Carvalho F., Tremblay A., Bello-Klein A., Rubin M.A., Morsch V.M., et al. Physical exercise prevents memory impairment in an animal model of hypertension through modulation of CD39 and CD73 activities and A2A receptor expression. J. Hypertens. 2019;37:135&#x2013;143. doi: 10.1097/HJH.0000000000001845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0000000000001845</ArticleId><ArticleId IdType="pubmed">30507864</ArticleId></ArticleIdList></Reference><Reference><Citation>Molero Y., Gumpert C., Serlachius E., Lichtenstein P., Walum H., Johansson D., Anckarsater H., Westberg L., Eriksson E., Halldner L. A study of the possible association between adenosine A2A receptor gene polymorphisms and attention-deficit hyperactivity disorder traits. Genes Brain Behav. 2013;12:305&#x2013;310. doi: 10.1111/gbb.12015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gbb.12015</ArticleId><ArticleId IdType="pubmed">23332182</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento F., Pousinha P.A., Correia A.M., Gomes R., Sebastiao A.M., Ribeiro J.A. Adenosine A2A receptors activation facilitates neuromuscular transmission in the pre-symptomatic phase of the SOD1(G93A) ALS mice, but not in the symptomatic phase. PLoS ONE. 2014;9:e104081. doi: 10.1371/journal.pone.0104081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0104081</ArticleId><ArticleId IdType="pmc">PMC4122437</ArticleId><ArticleId IdType="pubmed">25093813</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L., Heath P.R., Holden H., Kasher P., Kirby J., Shaw P.J. Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS. J. Neurosci. Off. J. Soc. Neurosci. 2007;27:9201&#x2013;9219. doi: 10.1523/JNEUROSCI.1470-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1470-07.2007</ArticleId><ArticleId IdType="pmc">PMC6672214</ArticleId><ArticleId IdType="pubmed">17715356</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera T.W., Steyn F.J., Ngo S.T., Borges K. CNS glucose metabolism in Amyotrophic Lateral Sclerosis: A therapeutic target? Cell Biosci. 2021;11:14. doi: 10.1186/s13578-020-00511-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-020-00511-2</ArticleId><ArticleId IdType="pmc">PMC7798275</ArticleId><ArticleId IdType="pubmed">33431046</ArticleId></ArticleIdList></Reference><Reference><Citation>Mailloux R.J., Beriault R., Lemire J., Singh R., Chenier D.R., Hamel R.D., Appanna V.D. The tricarboxylic acid cycle, an ancient metabolic network with a novel twist. PLoS ONE. 2007;2:e690. doi: 10.1371/journal.pone.0000690.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0000690</ArticleId><ArticleId IdType="pmc">PMC1930152</ArticleId><ArticleId IdType="pubmed">17668068</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki K., Masamoto K., Morimoto N., Kurata T., Mimoto T., Obata T., Kanno I., Abe K. Early and progressive impairment of spinal blood flow-glucose metabolism coupling in motor neuron degeneration of ALS model mice. J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab. 2012;32:456&#x2013;467. doi: 10.1038/jcbfm.2011.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2011.155</ArticleId><ArticleId IdType="pmc">PMC3293114</ArticleId><ArticleId IdType="pubmed">22068226</ArticleId></ArticleIdList></Reference><Reference><Citation>Weerasekera A., Crabbe M., Tome S.O., Gsell W., Sima D., Casteels C., Dresselaers T., Deroose C., Van Huffel S., Rudolf Thal D., et al. Non-invasive characterization of amyotrophic lateral sclerosis in a hTDP-43(A315T) mouse model: A PET-MR study. NeuroImage Clin. 2020;27:102327. doi: 10.1016/j.nicl.2020.102327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2020.102327</ArticleId><ArticleId IdType="pmc">PMC7352080</ArticleId><ArticleId IdType="pubmed">32653817</ArticleId></ArticleIdList></Reference><Reference><Citation>Cova E., Bongioanni P., Cereda C., Metelli M.R., Salvaneschi L., Bernuzzi S., Guareschi S., Rossi B., Ceroni M. Time course of oxidant markers and antioxidant defenses in subgroups of amyotrophic lateral sclerosis patients. Neurochem. Int. 2010;56:687&#x2013;693. doi: 10.1016/j.neuint.2010.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2010.02.004</ArticleId><ArticleId IdType="pubmed">20152873</ArticleId></ArticleIdList></Reference><Reference><Citation>Przedborski S., Donaldson D., Jakowec M., Kish S.J., Guttman M., Rosoklija G., Hays A.P. Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis. Ann. Neurol. 1996;39:158&#x2013;165. doi: 10.1002/ana.410390204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410390204</ArticleId><ArticleId IdType="pubmed">8967746</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R., Wiseman B., Deemagarn T., Jha V., Switala J., Loewen P.C. Comparative study of catalase-peroxidases (KatGs) Arch. Biochem. Biophys. 2008;471:207&#x2013;214. doi: 10.1016/j.abb.2007.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2007.12.008</ArticleId><ArticleId IdType="pubmed">18178143</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney D.J., Kaczor J.J., Bourgeois J., Yasuda N., Tarnopolsky M.A. Oxidative stress and antioxidant enzyme upregulation in SOD1-G93A mouse skeletal muscle. Muscle Nerve. 2006;33:809&#x2013;816. doi: 10.1002/mus.20542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20542</ArticleId><ArticleId IdType="pubmed">16583367</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung Y.H., Joo K.M., Lee Y.J., Cha C.I. Immunohistochemical study on the distribution of MnSOD in the central nervous system of the transgenic mice expressing a human Cu/Zn SOD mutation. Brain Res. 2003;990:215&#x2013;220. doi: 10.1016/S0006-8993(03)03457-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(03)03457-7</ArticleId><ArticleId IdType="pubmed">14568347</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H., Polymenidou M., Cleveland D.W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 2009;187:761&#x2013;772. doi: 10.1083/jcb.200908164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J.D. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann. Neurol. 2009;65:S3&#x2013;S9. doi: 10.1002/ana.21543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21543</ArticleId><ArticleId IdType="pubmed">19191304</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner B.J., Talbot K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog. Neurobiol. 2008;85:94&#x2013;134. doi: 10.1016/j.pneurobio.2008.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2008.01.001</ArticleId><ArticleId IdType="pubmed">18282652</ArticleId></ArticleIdList></Reference><Reference><Citation>Redler R.L., Dokholyan N.V. The complex molecular biology of amyotrophic lateral sclerosis (ALS) Prog. Mol. Biol. Transl. Sci. 2012;107:215&#x2013;262. doi: 10.1016/B978-0-12-385883-2.00002-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-385883-2.00002-3</ArticleId><ArticleId IdType="pmc">PMC3605887</ArticleId><ArticleId IdType="pubmed">22482452</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik R., Corrales C., Linsenmeier M., Alalami H., Sepanj N., Bitan G. Examination of SOD1 aggregation modulators and their effect on SOD1 enzymatic activity as a proxy for potential toxicity. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2020;34:11957&#x2013;11969. doi: 10.1096/fj.202000948R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202000948R</ArticleId><ArticleId IdType="pmc">PMC7903925</ArticleId><ArticleId IdType="pubmed">32701214</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lisio M., Kaczor J.J., Phan N., Tarnopolsky M.A., Boreham D.R., Parise G. Exercise training enhances the skeletal muscle response to radiation-induced oxidative stress. Muscle Nerve. 2011;43:58&#x2013;64. doi: 10.1002/mus.21797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21797</ArticleId><ArticleId IdType="pubmed">21171096</ArticleId></ArticleIdList></Reference><Reference><Citation>Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121&#x2013;126. doi: 10.1016/s0076-6879(84)05016-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0076-6879(84)05016-3</ArticleId><ArticleId IdType="pubmed">6727660</ArticleId></ArticleIdList></Reference><Reference><Citation>Leger L.A., Taylor A.W. The chronic effects of continuous and intermittent running upon lactate dehydrogenase activity of heart, fast and slow twitch muscles in the rat. J. Physiol. 1982;78:499&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">7186523</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>